Alembic Pharmaceuticals fell 1.26% to Rs 766.50 after the US Food and Drug Administration (USFDA) completed a current Good Manufacturing Practices inspection of the company's Karakhadi facility in ...

The report highlights opportunities in emerging trends and innovations in the pharmaceutical outsourcing sector, offering insights into new contracts and M&A deals. It advises on navigating regulatory ...

[Yangzhou, China - March 26, 2024] - Aurisco Pharmaceutical, a leading global pharmaceutical company, is excited to announce the completion of its investment in cGMP peptide manufacturing capacity at ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast projects the global active pharmaceutical ingredient market to expand from ...

TAIZHOU CITY, ZHEJIANG PROVINCE, CHINA, February 10, 2026 /EINPresswire.com/ -- The global pharmaceutical chemicals ...

New Delhi: With thousands of small drug manufacturers struggling to meet tougher quality norms, the government is weighing a year's extension to the deadline for complying with the revised good ...

Market opportunities lie in enhancing GMP compliance through comprehensive audit training. By integrating interview techniques, auditors can better uncover operational insights, deviations, and ...

This investment comes as LGM Pharma experiences sustained growth in prescription drug projects, including 505(b)(2) and Abbreviated New Drug Application (ANDA) programs. The Rosenberg facility ...

Biostin Pharma, Ahmedabad, is a WHO GMP-certified third-party pharma manufacturer committed to delivering high-quality pharmaceutical products to both Indian and international traders. With our ...

Piramal Pharma shares ended 1.69% higher at Rs 165.90 on BSE in the previous session. Market cap of the firm stood at Rs ...